In diabetes mellitus and obesity, plasma levels of proinflammatory adipokines, such as visfatin, leptin, and resistin, are increased, whereas the levels of adiponectin, which is an anti-inflammatory adipokine, are decreased. The gene discussed is ADIPOQ; the disease is diabetes mellitus.